Topic

Articles

The CDC’s Morbidity and Mortality Weekly Report show pediatric influenza hospitalization rates returned to levels that preceded the COVID-19 pandemic.

'High Severity' Flu Season Among Children Spotlights Importance of Vaccination

Mike Hollan is an assistant managing editor for 

 and can be reached at mhollan@mjhlifesciences.com.

A Q&A with Leslie Orne, CEO of Trinity Life Sciences, who discusses the latest developments in the life sciences industry and potential paths forward for companies in the space.

CEO of Trinity Life Sciences Discusses Healthcare Trends and How Companies Are Responding

Michael Wong is an emeritus board member of the Harvard Business School Healthcare Alumni Association (HBSHAA).

An overview of what biopharma C-Suites and their boards should consider when engaging with government and business leaders from China, the world’s second largest economy.

Should Biopharma C-Suites Still Engage With China? A Harvard Business School Healthcare Alumni Association Q&A with Professor F. Warren McFarlan

Webcasts

Webinar Date/Time: Tue, Dec 12, 2023 10:00 AM EST | 9:00 AM CT | 3:00 PM GMT | 4:00 PM CET

Unlocking Potential and Navigating Limitations of Using Real-World Evidence in Safety

is head of external affairs and ESG at Organon. In this role, she focuses on guiding and shaping how the company interacts with key stakeholders and the environment.

Nevertheless, it’s time to reassess how to leverage for greatest impact.

Pharma Giving is Still Strong Despite Post-Pandemic Shifts

C-Suites and their boards should remember that digital transformation is a key part of the larger focus of a profound business transformation.

As Biopharma Firms Finalize C-Suite Goals for 2024, Are Their Workforces Prepared to Execute? A Q&A With MIT’s Stephanie L. Woerner, PhD

Head of Global Commercial Innovation at Genmab

While there are still hurdles to overcome along the way, home healthcare could deliver better patient-centered cancer care, providing improved patient outcomes, enhanced quality of life, and reduced strain on resources. 


The Future State of Oncology: The Rise of Oncology Home Care 

Healthcare organizations can lower their risk of drug diversion by strengthening staffing, employee training, and technology.

Drug Diversion in Healthcare is a National Problem, but Recent Survey Shows a Promising Path Forward

Due to a global demand, treatments such as Adderall and Ritalin have been in short supply for the management of attention-deficit hyperactivity disorder. 

ADHD Drug Shortages: Causes, Implications, and Solutions 

The rise in popularity of GLP-1 weight-loss drugs, such as Ozempic, Wegovy, and Mounjaro, has had a wide-reaching impact across the healthcare industry and beyond.

Industry Trends